Original language | English |
---|---|
Pages (from-to) | 665-667 |
Number of pages | 3 |
Journal | Pharmacoeconomics |
Volume | 35 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2017 |
Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer": An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal
Bram L. T. Ramaekers*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore
*Corresponding author for this work
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review